Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 4/20 | 0.55 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.55 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.55 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.55 |
| ▸ | DRD2 | P14416 | 10/20 | 0.55 |
| ▸ | DRD3 | P35462 | 10/20 | 0.55 |
| ▸ | HTR1A | P08908 | 5/20 | 0.52 |
| ▸ | DRD1 | P21728 | 1/20 | 0.49 |
| ▸ | DRD4 | P21917 | 1/20 | 0.49 |
| ▸ | DRD5 | P21918 | 1/20 | 0.49 |
| ▸ | MAOA | P21397 | 1/20 | 0.47 |
| ▸ | MAOB | P27338 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9441353 | 1.00 | ACHE (0.55) | ACHECHRM2CHRM1CHRM3DRD2 | |
| Hydrochloric Acid SCHEMBL9441298 | 0.99 | ACHE (0.54) | ACHECHRM2CHRM1CHRM3DRD2 | |
| Hydrochloric Acid SCHEMBL9441304 | 0.99 | ACHE (0.54) | ACHECHRM2CHRM1CHRM3DRD2 | |
| SCHEMBL9119761 | 0.94 | ACHE (0.57) | ACHECHRM2CHRM1CHRM3DRD2 | |
| SCHEMBL9441067 | 0.94 | ACHE (0.57) | ACHECHRM2CHRM1CHRM3DRD2 | |
| SCHEMBL9441268 | 0.89 | ACHE (0.54) | ACHECHRM2CHRM1CHRM3DRD2 | |
| SCHEMBL9119906 | 0.89 | ACHE (0.54) | ACHECHRM2CHRM1CHRM3DRD2 | |
| Hydrochloric Acid SCHEMBL9122277 | 0.88 | ACHE (0.54) | ACHECHRM2CHRM1CHRM3DRD2 | |
| Hydrochloric Acid SCHEMBL9441299 | 0.88 | ACHE (0.54) | ACHECHRM2CHRM1CHRM3DRD2 | |
| SCHEMBL9441288 | 0.87 | DRD2 (0.55) | ACHECHRM2CHRM1CHRM3DRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0548664-B1 | 2,3,3a-5,9b-hexahydro-1H-benzo(e)indole derivatives | HOFFMANN LA ROCHE (CH) | 1995-05-31 | — | — | EP | disclosed |
| US-5318967-A | Cognition activators for alzheimer's disease, learning enhancement | HOFFMANN-LA ROCHE INC. (US) | 1994-06-07 | — | — | US | disclosed |
| US-5318966-A | Administering the enzyme inhibitor for treating alzheimer's disease, learning enhancement, brain disorders | HOFFMANN-LA ROCHE INC. (US) | 1994-06-07 | — | — | US | disclosed |
| EP-0548664-A1 | 2,3,3a-5,9b-hexahydro-1H-benzo(e)indole derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 1993-06-30 | — | — | EP | disclosed |